Mitotane Concentrations Influence the Risk of Recurrence in Adrenocortical Carcinoma Patients on Adjuvant Treatment.
Puglisi S, Calabrese A, Basile V, Ceccato F, Scaroni C, Simeoli C, Torlontano M, Cannavò S, Arnaldi G, Stigliano A, Malandrino P, Saba L, Altieri B, Della Casa S, Perotti P, Berchialla P, De Filpo G, Canu L, Loli P, Reimondo G, Terzolo M.
Puglisi S, et al. Among authors: arnaldi g.
J Clin Med. 2019 Nov 2;8(11):1850. doi: 10.3390/jcm8111850.
J Clin Med. 2019.
PMID: 31684071
Free PMC article.